Amundi’s Enfusion, Inc. ENFN Stock Holding History

Amundi’s Portfolio ENFN Stock Details ENFN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-16,435	Closed	-$146K	–	2205
2024 Q3	$146K	Hold	16,435	–	–	﹤0.01%	1723
2024 Q2	$141K	Buy	+16,435	New	+$150K	﹤0.01%	1647

Other funds holding ENFN

FMC

FTV Management Company San Francisco, California $541M AUM 34.37% 1-Year Est. Return

Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

LECM

Lead Edge Capital Management New York $408M AUM 4.05% 1-Year Est. Return

ACM

Ararat Capital Management Westport, Connecticut $178M AUM 26.61% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Amundi's ENFN Position: Q4 2024 in Review

Amundi sold out of Enfusion, Inc. (ENFN) in Q4 2024, closing a stake of 16,435 shares — an estimated $146K sold.

Amundi first reported a position in ENFN in Q2 2024 and held it in 2 quarters. The position peaked at $146K in Q3 2024. 132 funds tracked by Wall St. Rank hold ENFN as of Q4 2024.

Amundi reported no remaining Enfusion, Inc. position as of Q4 2024 after selling out during the quarter.
Amundi sold 16,435 Enfusion, Inc. shares in Q4 2024, an estimated $146K.
Amundi first reported a position in Enfusion, Inc. in Q2 2024 and held it in 2 quarters.
Amundi's Enfusion, Inc. position peaked at $146K in Q3 2024.
132 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q4 2024.

Based on Amundi's 13F filing for Q4 2024, filed 7 Feb 2025.